Review article: faecal calprotectin and histologic remission in ulcerative colitis.
Fiche publication
Date publication
février 2020
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
D'Amico F, Bonovas S, Danese S, Peyrin-Biroulet L
Lien Pubmed
Résumé
Histologic healing is emerging as a new therapeutic goal in both routine practice and clinical trials in ulcerative colitis (UC). However, it requires repeated endoscopies and biopsies. Faecal calprotectin is a non-invasive marker of mucosal healing (endoscopic and histologic healing).
Mots clés
cut-off, faecal calprotectin, histologic activity, ulcerative colitis
Référence
Aliment. Pharmacol. Ther.. 2020 Feb 12;: